Inventor
WEINER DAVID
US76 patents
⚠️ This page may combine multiple inventors who share the name “WEINER DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PENNSYLVANIA
22 patentsUS9913885B2Mar 13, 2018
Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
UNIV PENNSYLVANIA4 citations83
US11464841B2Oct 11, 2022
TERT immunogenic compositions and methods of treatment using the same
UNIV PENNSYLVANIA3 citations73
US10548971B2Feb 4, 2020
MERS-CoV vaccine
UNIV PENNSYLVANIA3 citations73
US11596678B2Mar 7, 2023
Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
UNIV PENNSYLVANIA2 citations72
US11045535B2Jun 29, 2021
Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
UNIV PENNSYLVANIA2 citations72
US10695421B2Jun 30, 2020
Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same
UNIV PENNSYLVANIA3 citations72
US10195268B2Feb 5, 2019
Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same
UNIV PENNSYLVANIA3 citations72
US11844830B2Dec 19, 2023
Vaccines for human papilloma virus and methods for using the same
UNIV PENNSYLVANIA0 citations63
US10905755B2Feb 2, 2021
Vaccines for human papilloma virus and methods for using the same
UNIV PENNSYLVANIA0 citations63
US12492243B2Dec 9, 2025
DNA antibody constructs for use against Pseudomonas aeruginosa
UNIV PENNSYLVANIA0 citations62
US12268735B2Apr 8, 2025
Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
UNIV PENNSYLVANIA0 citations62
US11980659B2May 14, 2024
Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
UNIV PENNSYLVANIA0 citations62
US11801298B2Oct 31, 2023
MERS-CoV vaccine
UNIV PENNSYLVANIA0 citations62
US11241496B2Feb 8, 2022
Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
UNIV PENNSYLVANIA0 citations62
US11135284B2Oct 5, 2021
MERS-CoV vaccine
UNIV PENNSYLVANIA0 citations62
US12419945B2Sep 23, 2025
Vaccines against Zika virus
UNIV PENNSYLVANIA0 citations61
US11648303B2May 16, 2023
Vaccines against zika virus
UNIV PENNSYLVANIA0 citations61
US11116838B2Sep 14, 2021
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
UNIV PENNSYLVANIA0 citations61
US10933130B2Mar 2, 2021
Vaccines with interleukin-33 as an adjuvant
UNIV PENNSYLVANIA0 citations61
US11208470B2Dec 28, 2021
DNA antibody constructs and method of using same
UNIV PENNSYLVANIA0 citations60
US11883484B2Jan 30, 2024
Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates
UNIV PENNSYLVANIA1 citations59
US10925961B2Feb 23, 2021
Vaccines with CD40 ligand as an adjuvant
UNIV PENNSYLVANIA1 citations59
WISTAR INST
8 patentsUS5714316AFeb 3, 1998
Chimeric envelope proteins for viral targeting
WISTAR INST99 citations96
US11230592B2Jan 25, 2022
DNA antibody constructs for use against middle east respiratory syndrome coronavirus
WISTAR INST2 citations68
US12194000B2Jan 14, 2025
Optimized synthetic consensus immunogenic compositions targeting chondroitin sulfate proteoglycan 4 (CSPG4)
WISTAR INST0 citations63
US12162925B2Dec 10, 2024
DNA-encoded monoclonal antibodies targeting the Ebolavirus glycoprotein
WISTAR INST1 citations62
US12357683B2Jul 15, 2025
Vaccines against Nipah virus, and methods of using same
WISTAR INST0 citations61
US12296001B2May 13, 2025
DNA vaccine against crimean-congo hemorrhagic fever virus (CCHFV)
WISTAR INST0 citations61
US12564628B2Mar 3, 2026
Epstein-BARR virus nucleic acid constructs and vaccines made therefrom, and methods of using same
WISTAR INST0 citations60
US11395851B2Jul 26, 2022
Epstein-Barr virus nucleic acid constructs and vaccines made therefrom, and methods of using same
WISTAR INST0 citations60
DSM IP ASSETS BV
4 patentsUS9034612B2May 19, 2015
Compositions and methods for making and modifying oils
DSM IP ASSETS BV7 citations82
US10308920B2Jun 4, 2019
Hydrolases, nucleic acids encoding them and methods for making and using them
DSM IP ASSETS BV3 citations70
US9499844B2Nov 22, 2016
Compositions and methods for making and modifying oils
DSM IP ASSETS BV1 citations61
US9243267B2Jan 26, 2016
Compositions and methods for making and modifying oils
DSM IP ASSETS BV2 citations61
DIVERSA CORP
3 patentsUS6979733B2Dec 27, 2005
Epoxide hydrolases, nucleic acids encoding them and methods of making and using them
DIVERSA CORP43 citations92
US6943001B2Sep 13, 2005
Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
DIVERSA CORP18 citations92
US7232672B2Jun 19, 2007
P450 enzymes, nucleic acids encoding them and methods of making and using them
DIVERSA CORP29 citations90
WEINER DAVID
3 patentsUS4662142AMay 5, 1987
Mounting device and method for making a dynamically stiff joint
WEINER DAVID16 citations73
US10087240B2Oct 2, 2018
DNA antibody constructs and method of using same
WEINER DAVID4 citations69
US10828363B1Nov 10, 2020
Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates
WEINER DAVID3 citations68
CARGILL INC
2 patentsVERENIUM CORP
2 patentsBORNSCHEUER UWE T
2 patentsACADIA PHARMACUETICALS INC
1 patentLAM DAVID
1 patentINOVIO PHARMACEUTICALS INC
1 patentBP CORP NORTH AMERICA INC
1 patentShowing the top 50 of 76 patents by PatentIndex Score.